Lannett Company FDA Inspection Record
Lannett Company is an FDA-registered facility (FEI 1819171) located in Seymour, IN, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 10 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Oct 21, 2022: Voluntary Action Indicated (VAI)
- Inspections on record
- 10 (1 OAI, 9 VAI)
- Last OAI inspection
- Oct 31, 2012
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 16, latest Jun 26, 2026
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Oct 21, 2022 | Voluntary Action Indicated (VAI) | No citations listed |
| Jul 23, 2018 | Voluntary Action Indicated (VAI) | No citations listed |
| Feb 2, 2018 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Batch production and Batch Control Record Requirements (21 CFR 211.188(b)) |
| Dec 16, 2014 | Voluntary Action Indicated (VAI) | No citations listed |
| Aug 15, 2013 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 31, 2012 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Equipment Design, Size and Location (21 CFR 211.63) Calibration/Inspection/Checking not done (21 CFR 211.68(a)) Extent of discrepancy, failure investigations (21 CFR 211.192) and 2 more |
| Aug 29, 2012 | Voluntary Action Indicated (VAI) | No citations listed |
| May 13, 2011 | Voluntary Action Indicated (VAI) | Sanitation--buildings not clean, free of infestation (21 CFR 211.56(a)) Identification of containers, lines, equipment (21 CFR 211.105(a)) |
| May 12, 2010 | Voluntary Action Indicated (VAI) | No citations listed |
| Sep 2, 2009 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jun 26, 2026 | Class II | D-0660-2026 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate… Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. |
| May 27, 2026 | Class II | D-0584-2026 | Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by… Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint. |
| Apr 24, 2026 | Class III | D-0533-2026 | Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company… Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. |
| Oct 10, 2025 | Class II | D-0096-2026 | Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle… Failed Dissolution Specifications |
| Aug 19, 2025 | Class II | D-0642-2025 | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and… Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine… |
| Aug 11, 2025 | Class II | D-0599-2025 | Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by… Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules… |
| Oct 25, 2024 | Class II | D-0112-2025 | Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed… Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity. |
| Nov 9, 2022 | Class III | D-0160-2023 | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules… and 1 more product Failed Impurity/Degradation Specifications |
| Feb 21, 2019 | Class III | D-0996-2019 | Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed… Failed Dissolution Specifications |
| Jul 7, 2015 | Class II | D-1236-2015 | Nitroglycerin Transdermal System 0.2 mg/hr (10 cm2), For Transdermal Use Only, 30 Systems… and 1 more product Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing. |
FDA record score
29 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
21 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-0660-2026, this FEI as the recalling firm | Jun 26, 2026 | 4 x 1 | 4 |
| Class II recall D-0584-2026, this FEI as the recalling firm | May 27, 2026 | 4 x 1 | 4 |
| Class II recall D-0096-2026, this FEI as the recalling firm | Oct 10, 2025 | 4 x 1 | 4 |
| Class II recall D-0642-2025, this FEI as the recalling firm | Aug 19, 2025 | 4 x 1 | 4 |
| Class II recall D-0599-2025, this FEI as the recalling firm | Aug 11, 2025 | 4 x 1 | 4 |
| Inspection classified VAI | Oct 21, 2022 | 6 x 0.6 | 3.6 |
| Class II recall D-0112-2025, this FEI as the recalling firm | Oct 25, 2024 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jul 23, 2018 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Feb 2, 2018 | 6 x 0.25 | 1.5 |
| Class II recall D-1236-2015, this FEI as the recalling firm | Jul 7, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Dec 16, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-009-2014, this FEI as the recalling firm | Sep 16, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 15, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Oct 31, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 29, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 13, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 12, 2010 | 10 years or older, so it adds no points | 0 |
| Class II recall D-686-2010, this FEI as the recalling firm | Apr 29, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 2, 2009 | 10 years or older, so it adds no points | 0 |
| Class II recall D-205-2008, this FEI as the recalling firm | Mar 21, 2008 | 10 years or older, so it adds no points | 0 |
| Class II recall D-053-5, this FEI as the recalling firm | Oct 22, 2004 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Lannett Company as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Lannett Company yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Lannett Company LLC
- Location
- Seymour, IN (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK
- Source
- decrs